30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Menlo Therapeutics Inc (MNLO)

Track

The most recent insider trading activity occurred on January 15, 2025, with a BUY transaction by LEPORE PATRICK G valued at $43,800. Prior to this, Patrick G. Lepore made several other BUY transactions in 2023 and 2021. Other notable transactions include BUYs by Harsch Mutya in March 2023 and by other executives in September 2020.
Stock chart
Ticker: MNLO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
LEPORE PATRICK G
1 purchase — total 43,800 USD
Buy 15 Jan 2025
Value US$4,145,168.91 | Price 309.19 | Shares 89,105
Buy 15 Nov 2023
Value US$3,166,110.19 | Price 213.32 | Shares 4,302
Buy 20 Mar 2023
Value US$49,680.00 | Price 2.48 | Shares 20,000
Buy 20 Mar 2023
Value US$25,000.00 | Price 2.50 | Shares 10,000
Planned buy 30 Nov 2021
Value US$12,698.75 | Price 1.02 | Shares 12,500
Sale 12 Aug 2021
Value US$755,740.31 | Price 2.23 | Shares 338,897
Buy 15 Mar 2021
Value US$92,562.50 | Price 7.41 | Shares 12,500
Buy 28 Jan 2021
Value US$9,999,999.33 | Price 2.37 | Shares 4,219,409
Planned buy 3 Dec 2020
Value US$85,425.00 | Price 1.71 | Shares 50,000
Buy 8 Sep 2020
Value US$103,567.50 | Price 1.38 | Shares 75,000
Buy 8 Sep 2020
Value US$58,480.00 | Price 1.46 | Shares 40,000
Buy 9 Jun 2020
Value US$4,999,998.70 | Price 1.85 | Shares 2,702,702
Sale 24 Jul 2018
Value US$95,625.00 | Price 7.65 | Shares 12,500
Sale 24 Jul 2018
Value US$3,729,375.00 | Price 7.65 | Shares 487,500
Buy 25 Jan 2018
Value US$1,700,000.00 | Price 17.00 | Shares 100,000
Buy 25 Jan 2018
Value US$606,662.00 | Price 17.00 | Shares 35,686
Buy 25 Jan 2018
Value US$4,393,344.00 | Price 17.00 | Shares 258,432
Buy 25 Jan 2018
Value US$606,662.00 | Price 17.00 | Shares 35,686
Buy 25 Jan 2018
Value US$4,393,344.00 | Price 17.00 | Shares 258,432
Buy 25 Jan 2018
Value US$4,505,000.00 | Price 17.00 | Shares 265,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-16 2025-01-15 B Purchase
2.5
LEPORE PATRICK G
Non-Executive Director
89,105 +25.0%
309.19
US$4,145,169 		89,105 +25.0% 309.19 US$4,145,169
2023-11-17 2023-11-15 B Purchase
2.5
LEPORE PATRICK G
Non-Executive Director
4,302 +1.6%
213.32
US$3,166,110 		4,302 +1.6% 213.32 US$3,166,110
2023-03-22 2023-03-20 B Purchase
2.5
LEPORE PATRICK G
Non-Executive Director
48,356 -26.9%
128.20
US$894,845 		48,356 -26.9% 128.20 US$894,845
2023-03-22 2023-03-20 B Purchase
Harsch Mutya

Chief Legal Officer and GC

Officer
10,000 +78.6%
2.50
US$25,000 		10,000 +78.6% 2.50 US$25,000
2021-12-02 2021-11-30 PP Planned purchase
2.5
LEPORE PATRICK G
Non-Executive Director
12,500 +25.0%
1.02
US$12,699 		12,500 +25.0% 1.02 US$12,699
2021-08-16 2021-08-12 S Sale
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
338,897 -5.9%
2.23
US$755,740 		338,897 -5.9% 2.23 US$755,740
2021-03-16 2021-03-15 B Purchase
2.5
LEPORE PATRICK G
Non-Executive Director
12,500 +100.0%
7.41
US$92,562 		12,500 +100.0% 7.41 US$92,562
2021-02-01 2021-01-28 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
4,219,409 +18.4%
2.37
US$9,999,999 		4,219,409 +18.4% 2.37 US$9,999,999
2020-12-07 2020-12-03 PP Planned purchase
2.5
LEPORE PATRICK G
Non-Executive Director
50,000 +inf%
1.71
US$85,425 		50,000 +inf% 1.71 US$85,425
2020-09-08 2020-09-08 B Purchase
3.2
Domzalski David

President and CEO

Executive Director
75,000 +6.0%
1.38
US$103,568 		75,000 +6.0% 1.38 US$103,568
2020-09-08 2020-09-08 B Purchase
3.3
Saik Andrew

Chief Financial Officer

Officer
40,000 +13.3%
1.46
US$58,480 		40,000 +13.3% 1.46 US$58,480
2020-06-11 2020-06-09 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
2,702,702 +13.4%
1.85
US$4,999,999 		2,702,702 +13.4% 1.85 US$4,999,999
2018-07-26 2018-07-24 S Sale Presidio Partners 2007 GP, L.P.
12,500 -20.4%
7.65
US$95,625 		12,500 -20.4% 7.65 US$95,625
2018-07-26 2018-07-24 S Sale Presidio Partners 2007 GP, L.P.
487,500 -20.4%
7.65
US$3,729,375 		487,500 -20.4% 7.65 US$3,729,375
2018-01-29 2018-01-25 B Purchase Remeditex Ventures LLC Large shareholder
100,000 +6.7%
17.00
US$1,700,000 		100,000 +6.7% 17.00 US$1,700,000
2018-01-29 2018-01-25 B Purchase Cha Albert Non-Executive Director
35,686 +inf%
17.00
US$606,662 		35,686 +inf% 17.00 US$606,662
2018-01-29 2018-01-25 B Purchase Cha Albert Non-Executive Director
258,432 +inf%
17.00
US$4,393,344 		258,432 +inf% 17.00 US$4,393,344
2018-01-29 2018-01-25 B Purchase Vivo Capital VIII, LLC Large shareholder
35,686 +inf%
17.00
US$606,662 		35,686 +inf% 17.00 US$606,662
2018-01-29 2018-01-25 B Purchase Vivo Capital VIII, LLC Large shareholder
258,432 +inf%
17.00
US$4,393,344 		258,432 +inf% 17.00 US$4,393,344
2018-01-29 2018-01-25 B Purchase venBio Global Strategic Fund II L.P. Large shareholder
265,000 +inf%
17.00
US$4,505,000 		265,000 +inf% 17.00 US$4,505,000
Explore more

More insider trading research around Menlo Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America